These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11524493)

  • 21. Increased detection of 14-3-3 protein in cerebrospinal fluid in Sporadic Creutzfeldt-Jakob Disease during the disease course.
    Giraud P; Biacabe AG; Chazot G; Later R; Joyeux O; Moene Y; Perret-Liaudet A
    Eur Neurol; 2002; 48(4):218-21. PubMed ID: 12422071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cerebrospinal fluid neuron-specific enolase as a useful indicator for the early diagnosis of Creutzfeldt-Jakob disease].
    Shibuya S; Wakayama Y; Jimi T
    Rinsho Shinkeigaku; 1997 Jul; 37(7):656; author reply 657. PubMed ID: 9396368
    [No Abstract]   [Full Text] [Related]  

  • 23. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease.
    Green AJ
    Neuropathol Appl Neurobiol; 2002 Dec; 28(6):427-40. PubMed ID: 12445159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion-weighted MRI in Creutzfeldt-Jakob disease: a better diagnostic marker than CSF protein 14-3-3?
    Mendez OE; Shang J; Jungreis CA; Kaufer DI
    J Neuroimaging; 2003 Apr; 13(2):147-51. PubMed ID: 12722497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autopsy-proven Creutzfeldt-Jakob disease in a patient with a negative 14-3-3 assay and nonspecific EEG and MRI.
    Donahue JE; Hanna PA; Hariharan S
    Neurol Sci; 2004 Feb; 24(6):411-3. PubMed ID: 14767688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease.
    Noguchi-Shinohara M; Hamaguchi T; Kitamoto T; Sato T; Nakamura Y; Mizusawa H; Yamada M
    Neurology; 2007 Jul; 69(4):360-7. PubMed ID: 17646628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of nervous system-specific proteins in cerebrospinal fluid in patients with early stage Creutzfeldt-Jakob disease.
    Jimi T; Wakayama Y; Shibuya S; Nakata H; Tomaru T; Takahashi Y; Kosaka K; Asano T; Kato K
    Clin Chim Acta; 1992 Oct; 211(1-2):37-46. PubMed ID: 1468153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of 14-3-3 protein in the CSF of genetic Creutzfeldt-Jakob disease.
    Rosenmann H; Meiner Z; Kahana E; Halimi M; Lenetsky E; Abramsky O; Gabizon R
    Neurology; 1997 Aug; 49(2):593-5. PubMed ID: 9270603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of Creutzfeldt-Jakob disease: effect of clinical criteria on incidence estimates. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease.
    Lanska DJ
    Neurology; 2001 May; 56(10):1422-3. PubMed ID: 11376210
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain-derived proteins in the CSF: do they correlate with brain pathology in CJD?
    Boesenberg-Grosse C; Schulz-Schaeffer WJ; Bodemer M; Ciesielczyk B; Meissner B; Krasnianski A; Bartl M; Heinemann U; Varges D; Eigenbrod S; Kretzschmar HA; Green A; Zerr I
    BMC Neurol; 2006 Sep; 6():35. PubMed ID: 16989662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid 14-3-3 protein: variability of sporadic Creutzfeldt-Jakob disease, laboratory standards, and quantitation.
    Aksamit AJ
    Arch Neurol; 2003 Jun; 60(6):803-4. PubMed ID: 12810481
    [No Abstract]   [Full Text] [Related]  

  • 33. 14-3-3 protein in the CSF of patients with rapidly progressive dementia.
    Huang N; Marie SK; Livramento JA; Chammas R; Nitrini R
    Neurology; 2003 Aug; 61(3):354-7. PubMed ID: 12913197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease.
    Green AJ; Knight RS; Macleod MA; Lowman A; Will RG
    Neurology; 2001 Apr; 56(7):986-7. PubMed ID: 11294951
    [No Abstract]   [Full Text] [Related]  

  • 35. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease.
    Geschwind MD; Martindale J; Miller D; DeArmond SJ; Uyehara-Lock J; Gaskin D; Kramer JH; Barbaro NM; Miller BL
    Arch Neurol; 2003 Jun; 60(6):813-6. PubMed ID: 12810484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid markers in the differentiation of molecular subtypes of sporadic Creutzfeldt-Jakob disease.
    Gmitterová K; Heinemann U; Krasnianski A; Gawinecka J; Zerr I
    Eur J Neurol; 2016 Jun; 23(6):1126-33. PubMed ID: 27029507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CSF detection of the 14-3-3 protein in unselected patients with dementia.
    Peoc'h K; Beaudry P; Lauprêtre N; Laplanche JL
    Neurology; 2002 Feb; 58(3):509-10. PubMed ID: 11839875
    [No Abstract]   [Full Text] [Related]  

  • 38. High neuron-specific enolase level of cerebrospinal fluid in the early stage of Creutzfeldt-Jakob disease.
    Wakayama Y; Shibuya S; Kawase J; Sagawa F; Hashizume Y
    Klin Wochenschr; 1987 Aug; 65(16):798-801. PubMed ID: 3309455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease.
    Sanchez-Juan P; Green A; Ladogana A; Cuadrado-Corrales N; Sáanchez-Valle R; Mitrováa E; Stoeck K; Sklaviadis T; Kulczycki J; Hess K; Bodemer M; Slivarichová D; Saiz A; Calero M; Ingrosso L; Knight R; Janssens AC; van Duijn CM; Zerr I
    Neurology; 2006 Aug; 67(4):637-43. PubMed ID: 16924018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cerebrospinal fluid diagnosis of Creutzfeldt-Jakob disease].
    Bernheimer H; Gatterbauer B; Radbauer C; Budka H
    Wien Med Wochenschr; 1998; 148(4):96-100. PubMed ID: 9611349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.